Management of New Vesicular Lesions During Tinea Capitis Treatment
Continue the current systemic antifungal therapy without interruption, as the new white fluid-filled vesicles on the scalp most likely represent a kerion—an inflammatory response to the dermatophyte infection that indicates the immune system is actively fighting the fungus, not treatment failure. 1
Understanding What's Happening
The appearance of these vesicles after one week of treatment, despite overall improvement, is actually a recognized phenomenon in tinea capitis management. This represents either:
- A kerion formation (boggy, pustular inflammatory mass)
- An "id" reaction (hypersensitivity response to fungal antigens)
Both are immune-mediated responses and paradoxically can appear as the body mounts a defense against the infection. The fact that the body and scalp lesions are otherwise improving is reassuring—this suggests the antifungal is working 2.
Immediate Management Steps
Continue Current Systemic Therapy
- Do not stop the oral antifungal you've already started
- If using griseofulvin: ensure dose is 15-20 mg/kg/day for 6-8 weeks (for a 6-year-old likely <50 kg) 1
- If using terbinafine: ensure appropriate weight-based dosing (likely 62.5 mg/day if <20 kg, or 125 mg/day if 20-40 kg) for 2-4 weeks 1
Add Adjunctive Measures
- Consider a short course of oral corticosteroids if the kerion is severe, boggy, or tender (though guidelines don't mandate this, it's common practice to reduce inflammation and prevent scarring)
- Apply antifungal shampoo (ketoconazole 2% or selenium sulfide 1%) twice weekly to reduce spore transmission 1
Critical Decision Point: Is This Treatment Failure?
No. The British Association of Dermatologists guidelines are clear about when to consider treatment failure 1:
- If clinical improvement is occurring (which you describe—body and scalp lesions improving), continue current therapy even if new inflammatory changes appear
- Only switch to second-line therapy if there is no initial clinical improvement after the expected timeframe
- In cases of clinical improvement but ongoing positive mycology, continue therapy for an additional 2-4 weeks 1
Species-Specific Considerations
Since you confirmed the diagnosis with scraping:
- If Microsporum species (common in children, especially M. canis): Griseofulvin is superior to terbinafine 1
- If Trichophyton species (T. tonsurans, T. violaceum): Terbinafine works well, but griseofulvin is also effective 1, 3
If you don't yet have culture results identifying the species, and the child is on terbinafine, consider that terbinafine has poor efficacy against Microsporum because it doesn't reach the scalp surface effectively in prepubertal children 1. If no improvement occurs by week 2-4, switch to griseofulvin.
Common Pitfalls to Avoid
Don't mistake inflammatory response for bacterial superinfection: Kerions can look purulent but are sterile inflammatory reactions. Antibiotics are not needed unless there's clear evidence of secondary bacterial infection (fever, systemic toxicity, positive bacterial culture) 4
Don't stop antifungals prematurely: The endpoint is mycological cure, not just clinical improvement 1. Repeat scraping/culture after clinical resolution to confirm eradication
Don't forget family screening: If this is T. tonsurans (anthropophilic), screen all family members and treat positive cases to prevent reinfection 1
Monitoring Plan
- Week 2: Assess clinical response. Inflammatory changes (vesicles, boggy areas) may persist but should not worsen
- Week 4-6: Expect significant clinical improvement
- Week 6-8: Repeat mycological sampling (scraping/culture) to confirm clearance before stopping therapy 1
- Trichoscopy can help: Reduction in corkscrew hairs, broken hairs, and perifollicular scales occurs before complete clinical resolution and can guide treatment duration 5
When to Escalate
Switch to second-line therapy (itraconazole 5 mg/kg/day for 2-4 weeks) only if 1:
- No clinical improvement by week 4-6
- Worsening despite appropriate therapy
- Culture reveals unexpected organism or treatment failure
The child can continue attending school while on appropriate systemic therapy 1.